Covance reported 10% revenue growth between the second quarter of this year and the same quarter last year, mostly due to central laboratories and late-stage development growth.
Datatrak has posted an operating profit, grown revenues and recorded the forth consecutive quarter-on-quarter increase in backlog in its latest results.
Protein technology and therapeutic specialist ProMetic managed to increase revenues in 2008, despite the challenging economic climate, but still posted a net loss of CN$20.2m (€12.1m).
Canadian drug outsourcing company Patheon has reported its first
quarterly loss since its inception in 1974, swinging from a net
profit of $6m (€4.9m) in Q1 of 2005 to a net loss of $11.5m in Q1
of 2006, as problems with production...
AstraZeneca has pulled the plug on a long-running service contract
with PDI, adding another blow to the company who last week reported
a dive from profit to loss in 2005, with a net loss of nearly $20m
(€16m), versus net income of...
LION bioscience has said it plans to cut its headcount by at least
50 per cent as part of a new restructuring drive, with most cuts
being felt at the company's facilities in Heidelberg, Germany.
Accelrys has reported a decrease in revenue in the second quarter
of the year. Revenues were slightly down but the company saw a
substantial increase in net loss for this year, which it attributed
to 'change in revenue recognition.'
Cardinal Health reported its long-delayed fourth-quarter financial
results yesterday, revealing a hike in profit and revenues for the
three months to end June, but lowered guidance for the first half
of this fiscal year.
US life science company Serologicals' decision to enter into a
€167.6 million merger with cell signalling specialist Upstate looks
to have been the right one as its third quarter performance
indicates its increasing presence...
Fisher Scientific has reported record second-quarter sales,
earnings and cash flow reflecting continued confidence in the
pharmaceutical sector. Fisher's performance is a sign the company's
strategy is working as it expands...
Germany's Evotec recording a loss in the first quarter of 2004 due
in part, to what it said was a difficult operating environment for
companies supplying drug discovery technologies.
Swiss-American laboratory instrument company Mettler-Toledo saw its
fourth-quarter revenues climb 7 per cent to $370 million (€290m)
although the weak dollar accounted for a large proportion of the
increase.
Flamel Technologies dips back into loss in the third quarter but
expects to be cash-flow positive for the year as a whole. License
and research revenues rise to $4.2m.
Evotec OAI has posted a strong set of figures in the first half of
2003 as operating losses are trimmed by a third and EBITDA enters
positive territory.
US company Molecular Devices, a supplier of bioanalytical
measurement systems, announced its revenues and earnings for the
quarter and year ended 31 December, 2002. Revenues for the fourth
quarter of 2002 were a healthy $30.2 million,...
